# Delafloxacin vs Vancomycin and Aztreonam for the Treatment of Acute Bacterial Skin and Skin Structure Infections

> **NCT01984684** · PHASE3 · COMPLETED · sponsor: **Melinta Therapeutics, Inc.** · enrollment: 850 (actual)

## Conditions studied

- Skin and Subcutaneous Tissue Bacterial Infections
- Skin Structures and Soft Tissue Infections

## Interventions

- **DRUG:** delafloxacin
- **DRUG:** vancomycin
- **DRUG:** aztreonam

## Key facts

- **NCT ID:** NCT01984684
- **Lead sponsor:** Melinta Therapeutics, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-05
- **Primary completion:** 2015-12
- **Final completion:** 2016-01
- **Target enrollment:** 850 (ACTUAL)
- **Last updated:** 2017-11-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01984684

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01984684, "Delafloxacin vs Vancomycin and Aztreonam for the Treatment of Acute Bacterial Skin and Skin Structure Infections". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT01984684. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*